Membrane Bioreactor (MBR) Pre-Treatment — Role of Chemical Coagulation
Membrane bioreactors (MBRs) have become one of the fastest-growing wastewater treatment technologies, combining biological treatment with membrane filtration to produce exceptionally high-quality effluent. However, MBR systems are also expensive to operate and sensitive to fouling. Proper pre-treatment is essential for protecting membranes, maintaining flux rates, extending membrane life, and minimizing cleaning frequency. Chemical coagulation plays a critical and often underappreciated role in MBR pre-treatment, reducing fouling potential and improving overall system performance. This guide examines how chemical coagulation supports MBR operation and how to optimize it for maximum benefit.
What Is an MBR and Why Does Pre-Treatment Matter?
A membrane bioreactor combines a suspended-growth biological reactor (like an activated sludge process) with ultrafiltration (UF) or microfiltration (MF) membranes. The membranes replace conventional secondary clarification, providing a physical barrier that retains all suspended solids — including biomass — producing an effluent with near-zero turbidity that is often suitable for reuse or direct discharge.
While MBRs offer significant advantages over conventional activated sludge — smaller footprint, higher effluent quality, better sludge retention — they also face a major operational challenge: membrane fouling.
Membrane fouling occurs when particles, colloids, organic matter, and biological materials accumulate on or within the membrane pores, reducing permeability and increasing the energy required to maintain flux. Fouling is the primary factor limiting MBR performance and is responsible for the majority of operational costs beyond energy and chemical consumption.
Pre-treatment reduces the fouling load on the MBR by removing or altering constituents that would otherwise cause membrane fouling. While physical pre-treatment (screening, grit removal, primary sedimentation) addresses large and gritty material, chemical coagulation targets the colloidal and dissolved organic matter that causes the most persistent and reversible fouling.
Types of Membrane Fouling
To understand how coagulation helps, it’s important to recognize the different types of membrane fouling and their causes:
| Fouling Type | Primary Cause | Reversibility |
|---|---|---|
| Particulate fouling | Suspended solids, sludge flocs | Reversible (backwash/relaxation) |
| Colloidal fouling | Colloidal particles, clay, humic substances | Partially reversible |
| Organic fouling | Dissolved organic carbon (DOC), proteins, polysaccharides, SMP/EPS | Slowly reversible / irreversible |
| Biofouling | Microbial growth on membrane surface | Requires chemical cleaning |
| Inorganic scaling | Mineral precipitation (CaCO3, CaSO4, etc.) | Chemical cleaning (acid) |
Chemical coagulation primarily addresses colloidal and organic fouling by aggregating colloidal particles and adsorbing dissolved organic matter into flocs that are removed before they reach the membranes. It can also reduce biofouling potential by removing biodegradable organic material that would otherwise support biofilm growth.
How Coagulation Reduces Membrane Fouling
Chemical coagulation protects MBR membranes through several mechanisms:
1. Colloid Removal
Colloidal particles (typically 0.001-1 μm in size) are a major cause of membrane fouling because they are too small to be effectively retained by biological flocs but large enough to block membrane pores. PAC and other metal coagulants neutralize the negative charge on colloidal particles, causing them to aggregate into larger flocs that are easily removed by sedimentation or directly incorporated into the activated sludge matrix.
2. Dissolved Organic Carbon (DOC) Removal
Dissolved organic matter, particularly humic and fulvic acids, proteins, and polysaccharides, is a major contributor to organic membrane fouling. These compounds adsorb onto the metal hydroxide flocs formed by coagulants through charge neutralization and enmeshment. The optimal pH for NOM (natural organic matter) removal by aluminum coagulants is typically pH 5.5-6.5, where charge neutralization is most effective.
3. Reduction of SMP and EPS Precursor Material
Soluble microbial products (SMP) and extracellular polymeric substances (EPS) produced by activated sludge bacteria are widely recognized as the primary causes of MBR membrane fouling. By removing readily biodegradable organic matter before it enters the bioreactor, pre-coagulation reduces the organic loading on the biological system and consequently reduces SMP and EPS production. Additionally, the metal coagulant that carries over into the bioreactor can interact with EPS, modifying its characteristics and reducing its fouling potential.
4. Floc Size and Structure Modification
The presence of metal coagulants in the mixed liquor can alter the characteristics of activated sludge flocs. Studies have shown that adding iron or aluminum coagulants to MBR systems increases floc size, improves floc structure, and reduces the concentration of fine particles in the mixed liquor. Larger, denser flocs form a more porous cake layer on the membrane surface, which is more permeable and easier to remove by backwashing.
Coagulant Selection for MBR Pre-Treatment
Polyaluminum Chloride (PAC)
PAC is the most widely used coagulant for MBR pre-treatment, and for good reason. Its pre-polymerized structure provides excellent charge neutralization and floc formation across a wider pH range than alum. PAC produces dense, fast-settling flocs that effectively remove colloids and organic matter. In MBR applications, residual aluminum in the mixed liquor can also provide ongoing benefits by interacting with EPS and modifying cake layer characteristics.
When using PAC in MBR systems, it’s important to monitor mixed liquor aluminum concentrations. While moderate levels (50-200 mg Al/kg MLSS) can be beneficial, excessive aluminum accumulation may affect biological activity or contribute to inorganic fouling. For more on PAC properties, see our PAC shelf life and storage guide.
Ferric Chloride / Ferric Sulfate
Iron-based coagulants are also used in MBR pre-treatment, particularly when phosphorus removal is also required. Iron coagulants are effective at removing organic matter and can provide similar fouling reduction benefits as PAC. Some studies suggest that iron may have a greater effect on EPS modification due to its stronger affinity for certain functional groups in organic matter.
However, iron coagulants add color to the mixed liquor and can contribute to inorganic scaling if not properly managed. The choice between aluminum and iron coagulants depends on the specific wastewater characteristics, regulatory requirements, and overall treatment objectives, including phosphorus removal targets.
Polymeric Coagulants and Flocculants
Organic polymeric coagulants like polyDADMAC can be used alone or in combination with metal coagulants for MBR pre-treatment. They are particularly effective for charge neutralization and produce less sludge than metal coagulants. However, there is concern that residual polymer could contribute to organic fouling if overdosed.
Anionic and cationic PAM flocculants are sometimes used as flocculation aids to improve floc size and settleability in primary treatment. When properly dosed, PAM can significantly improve solid-liquid separation and reduce the solids loading on the MBR. Care must be taken to avoid overdosing, as excess polymer can cause fouling. For more on PAM selection, see our PAM molecular weight and charge density guide.
Where to Add Coagulant in the MBR Process
The point of coagulant addition significantly impacts its effectiveness and the overall process economics. There are three common approaches:
1. Pre-Coagulation (Before Bioreactor)
Adding coagulant before the biological reactor, typically in a primary treatment step with sedimentation or flotation, is the traditional approach. This removes colloids and organic matter before they enter the bioreactor, reducing organic loading and SMP/EPS production. The advantage is that most of the coagulant sludge is removed separately from the biological sludge, reducing metal accumulation in the mixed liquor.
Pre-coagulation can be implemented with a dedicated coagulation/flocculation/sedimentation process, or more simply with inline coagulation followed by a DAF system for high-rate separation. The EPA recommends proper pre-treatment as a key factor in MBR system longevity and performance.
2. In-Bioreactor Dosing
Adding coagulant directly into the MBR bioreactor (aeration tank) is a common practice, especially in retrofits where space for pre-treatment is limited. The coagulant mixes with the activated sludge and forms larger, denser flocs that are less prone to cause membrane fouling. Metal coagulants also interact with EPS in the mixed liquor, reducing its fouling potential.
The advantage of in-bioreactor dosing is simplicity — no additional tanks or equipment are needed. The disadvantage is that all the coagulant and removed organic matter remains in the biological system, increasing mixed liquor suspended solids (MLSS) concentration and potentially affecting biological treatment performance at very high doses.
3. Hybrid Approach
Many facilities use a combination approach: a primary coagulation step for bulk removal of colloids and organic matter, plus a smaller continuous dose into the bioreactor for EPS control and floc modification. This provides the maximum fouling reduction benefit while maintaining manageable metal accumulation in the biological system.
Optimal Dosage and Performance Monitoring
Determining the optimal coagulant dosage for MBR pre-treatment requires balancing fouling reduction against operating cost and potential side effects. While jar testing provides a good starting point, the ultimate measure of success is improved membrane performance.
Typical Dosage Ranges
- Pre-coagulation with PAC: 20-100 mg/L as 10% Al₂O₃ product, depending on raw water COD and turbidity
- In-bioreactor PAC dosing: 5-30 mg/L as product (typically 0.5-3 mg/L as Al)
- Ferric chloride pre-coagulation: 20-80 mg/L
- PolyDADMAC as coagulant aid: 1-5 mg/L
- Anionic PAM as flocculant aid: 0.1-1 mg/L
These are general starting points. The optimal dose must be determined through on-site evaluation, monitoring key performance indicators like:
- Transmembrane pressure (TMP): The rate of TMP increase is the most direct indicator of fouling rate. A slower TMP rise indicates reduced fouling.
- Permeability: Flux divided by TMP. Higher permeability means less fouling.
- Cleaning frequency: Longer intervals between chemical cleanings (CIP) indicate better fouling control.
- Effluent quality: COD, BOD, color, and turbidity removal indicate overall treatment effectiveness.
- Sludge characteristics: MLSS, sludge volume index (SVI), floc size distribution, and EPS content.
- Mixed liquor metal content: Monitor aluminum or iron accumulation in the sludge.
Potential Challenges and Considerations
1. Sludge Production
Adding metal coagulants increases sludge production due to the additional metal hydroxide mass and the organic matter that is removed. Pre-coagulation generates chemical sludge that must be thickened and dewatered separately or combined with biological sludge. In-bioreactor dosing increases MLSS concentration and reduces sludge age, which may require adjustments to the wasting rate. Increased sludge production also increases sludge dewatering costs.
2. Metal Accumulation in Sludge
Continuous coagulant addition to the bioreactor results in accumulation of aluminum or iron in the mixed liquor and in the waste sludge. This may affect sludge disposal options (e.g., land application limits for metals) and can impact biological processes at very high concentrations. Monitoring mixed liquor metal concentrations is important for long-term operation.
3. pH and Alkalinity Effects
Metal coagulants consume alkalinity and lower pH. While this effect is smaller for PAC than for alum or ferric chloride, it can still be significant at higher doses. Ensure that the bioreactor pH remains within the optimal range for nitrification (typically pH 7.0-8.0). If necessary, add alkalinity (e.g., sodium hydroxide or lime) to compensate. For more on this topic, see our article on alkalinity and coagulation.
4. Biological Process Impacts
At typical MBR dosing rates, coagulants generally have minimal negative impact on biological treatment performance. In fact, by reducing toxic or inhibitory organic compounds, pre-coagulation can actually improve biological performance. However, at very high doses, metal coagulants may affect enzyme activity or cause phosphorus limitation in the bioreactor. Monitor biological performance parameters (ammonia removal, BOD removal, sludge activity) when making significant changes to coagulant dosage.
Conclusion
Chemical coagulation is a powerful tool for MBR pre-treatment that can significantly reduce membrane fouling, extend membrane life, and lower operating costs. By removing colloids, dissolved organic matter, and fine particles before they reach the membrane — and by modifying mixed liquor floc characteristics — coagulants like PAC and ferric chloride improve permeability, reduce transmembrane pressure rise, and extend cleaning intervals. The optimal approach depends on your specific wastewater characteristics, MBR configuration, and treatment objectives, but most facilities can benefit from incorporating chemical coagulation into their MBR pre-treatment strategy.
For expert guidance on MBR pre-treatment optimization, or for high-quality PAC and PAM products tailored to membrane bioreactor applications, contact HydroChemix. Our technical team can help with coagulant selection, dosage optimization, and process troubleshooting.
Frequently Asked Questions
Why is pre-treatment important for MBR systems?
Pre-treatment protects MBR membranes from fouling, which is the main operational challenge and cost driver for MBR systems. Without adequate pre-treatment, colloidal particles, dissolved organic matter, and other contaminants rapidly foul the membranes, leading to reduced flux, higher energy consumption, more frequent cleaning, and shorter membrane life. Chemical pre-coagulation is particularly effective at removing the colloidal and organic fractions that cause the most persistent fouling.
Which coagulant is best for MBR pre-treatment?
Polyaluminum chloride (PAC) is generally the preferred coagulant for MBR applications due to its wide effective pH range, low alkalinity consumption, and excellent floc formation. Ferric chloride is also used, especially when phosphorus removal is needed. The optimal choice depends on your specific wastewater characteristics, required effluent quality, and overall treatment goals. Always verify through on-site testing with your actual wastewater.
How much PAC should I add to an MBR system?
Dosage depends on the application point and wastewater characteristics. For pre-coagulation before the bioreactor, typical PAC doses range from 20-100 mg/L (as 10% Al₂O₃ product). For in-bioreactor dosing, typical doses are 5-30 mg/L. Start with the lower end of the range and optimize based on membrane performance (TMP rise rate, permeability) and effluent quality. Avoid overdosing, as excessive coagulant can increase sludge production and may not provide additional fouling benefit.
Does coagulant affect the biology in an MBR?
At typical dosing rates, coagulants generally have minimal negative impact on biological processes and may even improve performance by removing toxic or inhibitory compounds. However, very high doses can increase MLSS concentration, reduce sludge age, and potentially affect nitrification if metal concentrations become too high. Monitor biological performance parameters (ammonia removal, OUR, etc.) when making dosage changes.
What’s the best point to add coagulant — before or in the bioreactor?
Both approaches have advantages. Pre-coagulation removes contaminants before they enter the bioreactor, reducing organic loading and minimizing metal accumulation in the mixed liquor, but requires additional tankage. In-bioreactor dosing is simpler and provides direct EPS modification benefits but increases MLSS and metal accumulation. Many facilities achieve the best results with a hybrid approach: primary pre-coagulation for bulk removal plus a smaller in-bioreactor dose for floc and EPS control.
Can I use PAM in an MBR system?
Yes, PAM can be used in MBR systems, but with caution. Anionic or nonionic PAM is sometimes added as a flocculant aid in pre-treatment to improve floc size and settleability, which reduces solids loading on the MBR. Very small doses of cationic PAM have also been studied for in-bioreactor use to reduce fouling. However, PAM must be carefully dosed because excess polymer can itself cause membrane fouling. Always start with very low doses and monitor membrane permeability closely.